Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 4, 2011, Pages 559-563

  Moens, An L ^a   Kietadisorn, Rinrada ^a   Lin, Judy Y ^a   Kass, David ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Endothelial dysfunction; ENOS uncoupling; Myocardial dysfunction; Sapropterin; Tetrahydrobiopterin; Ventricular remodeling and heart failure

Indexed keywords

ANTIOXIDANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOENZYME; NITRIC OXIDE SYNTHASE; OXYGENASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SAPROPTERIN; SCAVENGER; TETRAHYDROBIOPTERIN;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CELL PROTECTION; DRUG DOSE ESCALATION; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL STUDY; HUMAN; HYPERTENSION; ISCHEMIA; MYOCARDIAL DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SICKLE CELL ANEMIA;

ANIMALS; ANTIOXIDANTS; BIOPTERIN; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEART; HUMANS; ISOENZYMES; MOLECULAR TARGETED THERAPY; MYOCARDIUM; NITRIC OXIDE SYNTHASE;

ANIMALIA;

EID: 79960803194     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.03.009     Document Type: Review

References (56)

1. Raman C.S., Li H., Martásek P., Král V., Masters B.S., Poulos T.L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for Pterin function involving a novel metal center. Cell 1998, 95(7):939-950.
2. Moens A.L., Takimoto E., Tocchetti C.G., Chakir K., Bedja D., Cormaci G., et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008, 117(20):2626-2636.
3. Takikawa S.I., Curtius H.C., Redweik U., Leimbacher W., Ghisla S. Biosynthesis of tetrahydrobiopterin. Eur J Biochem 1986, 161(2):295-302.
4. Thony B., Auerbach G., Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000, 347(1):1-16.
5. Alp N.J., Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004, 24(3):413-420.
6. Chalupsky K., Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2005, 102(25):9056-9061.
7. Seujange Y., Eiam-Ong S., Tirawatnapong T. Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion. Am J Nephrol 2008, 28(4):692-700.
8. Crabtree M.J., Tatham A.L., Al-Wakeel Y., Warrick N., Hale A.B., Cai S., et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status. J Biol Chem 2009, 284(2):1136-1144.
9. Vásquez-Vivar J., Whitsett J., Martásek P., Hogg N., Kalyanaraman B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med 2001, 31(8):975-985.
10. Huie R.E., Padmaja S. The reaction of no with superoxide. Free Radic Res 1993, 18(4):195-199.
11. Vásquez-Vivar J., Martásek P., Whitsett J., Joseph J., Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 2002, 362(3):733-739.
12. Crabtree M.J., Smith C.L., Lam G., Goligorsky M.S., Gross S.S. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 2008, 294(4):H1530-H1540.
13. Crabtree M.J., Tatham A.L., Hale A.B., Alp N.J., Channon K.M. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling. J Biol Chem 2009, 284(41):28128-28136.
14. Sugiyama T., Levy B.D., Michel T. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem 2009, 284(19):12691-12700.
15. Dedkova E.N., Blatter L.A. Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol 2009, 587(4):851-872.
16. Higashi Y., Sasaki S., Nakagawa K., Fukuda Y., Matsuura H., Oshima T., et al. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens 2002, 15(4 Pt 1):326-332.
17. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399(6736):601-605.
18. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399(6736):597-601.
19. Chavakis E., Dernbach E., Hermann C., Mondorf U.F., Zeiher A.M., Dimmeler S. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 2001, 103(16):2102-2107.
20. Heitzer T., Krohn K., Albers S., Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 2000, 86(2):e36-e41.
21. Chen W., D.L., Chen C.A., Hemann C., Chen Y.R., Berka V., et al. Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition. Biochemistry 2010, 49:3129-3137.
22. Ueda S., Matsuoka H., Miyazaki H., Usui M., Okuda S., Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. J Am Coll Cardiol 2000, 35(1):71-75.
23. Ozaki M., Kawashima S., Yamashita T., Hirase T., Ohashi Y., Inoue N., et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 2002, 110(3):331-340.
24. Dhillon B., Badiwala M.V., Maitland A., Rao V., Li S.H., Verma S. Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction. Mol Cell Biochem 2003, 247(1):223-227.
25. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997, 99(1):41-46.
26. Cosentino F., et al. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21(4):496-502.
27. Kinoshita H., Milstien S., Wambi C., Katusic Z.S. Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol Heart Circ Physiol 1997, 273(2):H718-H724.
28. Khoo J.P., Bursill C., Alp N.J., McAteer M.A., Channon K.M. Endothelial tetrahydrobiopterin deficiency accelerates atherosclerotic progression by nitric oxide synthase uncoupling (Abstract). Circulation 2005, 112:116.
29. Wang C.H., Li S.H., Weisel R.D., Fedak P.W., Hung A., Li R.K., et al. Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury. Am J Physiol Regul Integr Comp Physiol 2005, 289(2):R299-R304.
30. Lam C.F., Peterson T.E., Richardson D.M., Croatt A.J., d'Uscio L.V., Nath K.A., et al. Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2006, 290(2):H786-H793.
31. Widder J.D., Chen W., Li L., Dikalov S., Thöny B., Hatakeyama K., et al. Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res 2007, 101(8):830-838.
32. Li L., Rezvan A., Salerno J.C., Husain A., Kwon K., Jo H., et al. GTP cyclohydrolase I Phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide. Circ Res 2010, 106(2):328-336.
33. Satoh M., Fujimoto S., Arakawa S., Yada T., Namikoshi T., Haruna Y., et al. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 2008, 23(12):3806-3813.
34. Hattori Y., Akimoto K., Gross S.S., Hattori S., Kasai K. Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 2005, 48(6):1066-1074.
35. Xu J., Wang S., Wu Y., Song P., Zou M.H. Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension. Hypertension 2009, 54(3):625-632.
36. Cosentino F., Patton S., d'Uscio L.V., Werner E.R., Werner-Felmayer G., Moreau P., et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998, 101(7):1530-1537.
37. Hong H.J., Hsiao G., Cheng T.H., Yen M.H. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001, 38(5):1044-1048.
38. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111(8):1201-1209.
39. Takimoto E., Champion H.C., Li M., Ren S., Rodriguez E.R., Tavazzi B., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 2005, 115(5):1221-1231.
40. Silberman G.A., Fan T.H., Liu H., Jiao Z., Xiao H.D., Lovelock J.D., et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010, 121(4):519-528.
41. Verma S., Maitland A., Weisel R.D., Fedak P.W., Pomroy N.C., Li S.H., et al. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg 2002, 123(6):1074-1083.
42. Dumitrescu C., Biondi R., Xia Y., Cardounel A.J., Druhan L.J., Ambrosio G., et al. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci 2007, 104(38):15081-15086.
43. Yamashiro S., Noguchi K., Matsuzaki T., Miyagi K., Nakasone J., Sakanashi M., et al. Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts. J Thorac Cardiovasc Surg 2002, 124(4):775-784.
44. Yamashiro S., Noguchi K., Matsuzaki T., Miyagi K., Nakasone J., Sakanashi M., et al. Role of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts. J Cardiovasc Surg (Torino) 2003, 44(1):37-49.
45. Chen Q., Kim E.E., Elio K., Zambrano C, Krass S., Teng J.C., et al. The role of tetrahydrobiopterin and dihydrobiopterin in ischemia/reperfusion injury when given at reperfusion. Adv Pharmacol Sci 2010, 2010:1-11.
46. Elio K., Kim E.E.J., Chen Q., Kay H.Y., Adams J., Young L.H. Tetrahydrobiopterin (BH4) attenuates neutrophil adhesion/transmigration in myocardial ischemia/reperfusion injury. FASEB J 2007, 21(6):A1145-c.
47. Katusic Z.S., d'Uscio L.V., Nath K.A. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci 2009, 30(1):48-54.
48. Vásquez-Vivar J. Tetrahydrobiopterin, superoxide, and vascular dysfunction. Free Radic Biol Med 2009, 47(8):1108-1119.
49. Kidd G.A., Hong H., Majid A., Kaufman D.I., Chen A.F. Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke. Stroke 2005, 36(12):2705-2711.
50. Hasegawa H., Sawabe K., Nakanishi N., Wakasugi O.K. Delivery of exogenous tetrahydrobiopterin (BH4) to cells of target organs: role of salvage pathway and uptake of its precursor in effective elevation of tissue BH4. Mol Genet Metab 2005, 86(Supplement 1):2-10.
51. Suckling C.J., Gibson C.L., Huggan J.K., Morthala R.R., Clarke B., Kununthur S., et al. 6-Acetyl-7,7-dimethyl-5,6,7,8-tetrahydropterin is an activator of nitric oxide synthases. Bioorg Med Chem Lett 2008, 18(5):1563-1566.
52. Hattori Y., Nakanishi N., Akimoto K., Yoshida M., Kasai K. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2003, 01. ATV.0000054659.72231.A1.
53. Moens A.L., Vrints C.J., Claeys M.J., Timmermans J.P., Champion H.C., Kass D.A. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008, 294(5):H1971-H1977.
54. Hyndman M.E., Verma S., Rosenfeld R.J., Anderson T.J., Parsons H.G. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 2002, 282(6):H2167-H2172.
55. Wang Y., Subudhi S.K., Anders R.A., Lo J., Sun Y., Blink S., et al. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 2005, 115(3):711-717.
56. Szabó G., Seres L., Soós P., Gorenflo M., Merkely B., Horkay F., et al. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass. Eur J Cardiothorac 2011, 40(3):695-700.